[Studies on the serum levels of a carbohydrate antigen 19-9 (CA 19-9) in patients with ovarian cancer]. 1984

T Miyoshi, and H Nishimura, and N Ookura, and H Morisaki, and H Kobayashi, and T Tasaki, and H Ushijima, and M Yakushiji

UI MeSH Term Description Entries
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003537 Cystadenoma A benign neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. In some instances, considerable portions of the neoplasm, or even the entire mass, may be cystic. (Stedman, 25th ed) Cystadenomas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D015295 Antigens, Tumor-Associated, Carbohydrate Carbohydrate antigens expressed by malignant tissue. They are useful as tumor markers and are measured in the serum by means of a radioimmunoassay employing monoclonal antibodies. Antigens, Carbohydrate, Tumor-Associated,CA Antigens,Cancer-Associated Carbohydrate Antigens,Carbohydrate Antigens, Tumor-Associated,Tumor-Associated Carbohydrate Antigens,Antigen, Carcinoma-Associated,CA Antigen,CA(Oxford) Antigen,Carcinoma-Associated Antigen,Epitectin,Antigen, CA,Antigen, Carcinoma Associated,Antigens, CA,Antigens, Cancer-Associated Carbohydrate,Antigens, Tumor-Associated Carbohydrate,Cancer Associated Carbohydrate Antigens,Carbohydrate Antigens, Cancer-Associated,Carbohydrate Antigens, Tumor Associated,Carcinoma Associated Antigen,Tumor Associated Carbohydrate Antigens

Related Publications

T Miyoshi, and H Nishimura, and N Ookura, and H Morisaki, and H Kobayashi, and T Tasaki, and H Ushijima, and M Yakushiji
March 2018, The Journal of the Association of Physicians of India,
T Miyoshi, and H Nishimura, and N Ookura, and H Morisaki, and H Kobayashi, and T Tasaki, and H Ushijima, and M Yakushiji
June 2001, Clinical chemistry and laboratory medicine,
T Miyoshi, and H Nishimura, and N Ookura, and H Morisaki, and H Kobayashi, and T Tasaki, and H Ushijima, and M Yakushiji
March 1991, Changgeng yi xue za zhi,
T Miyoshi, and H Nishimura, and N Ookura, and H Morisaki, and H Kobayashi, and T Tasaki, and H Ushijima, and M Yakushiji
February 1988, The American journal of gastroenterology,
T Miyoshi, and H Nishimura, and N Ookura, and H Morisaki, and H Kobayashi, and T Tasaki, and H Ushijima, and M Yakushiji
January 1986, Gan to kagaku ryoho. Cancer & chemotherapy,
T Miyoshi, and H Nishimura, and N Ookura, and H Morisaki, and H Kobayashi, and T Tasaki, and H Ushijima, and M Yakushiji
January 1988, European journal of gynaecological oncology,
T Miyoshi, and H Nishimura, and N Ookura, and H Morisaki, and H Kobayashi, and T Tasaki, and H Ushijima, and M Yakushiji
June 2016, The American journal of case reports,
T Miyoshi, and H Nishimura, and N Ookura, and H Morisaki, and H Kobayashi, and T Tasaki, and H Ushijima, and M Yakushiji
August 2020, Biomedicines,
T Miyoshi, and H Nishimura, and N Ookura, and H Morisaki, and H Kobayashi, and T Tasaki, and H Ushijima, and M Yakushiji
February 2014, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
T Miyoshi, and H Nishimura, and N Ookura, and H Morisaki, and H Kobayashi, and T Tasaki, and H Ushijima, and M Yakushiji
March 1985, Meditsinskaia radiologiia,
Copied contents to your clipboard!